🙌🧬It’s official: the first TCR gene therapy for the treatment of cancer received U.S. FDA approval this evening. A milestone event for the oncology community and the 2nd cell therapy approved for solid cancers! Adaptimmune #Tcellpower adaptimmune.com/investors-and-…

Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors. businesswire.com/news/home/2024…

This trial will answer a critical❓for patients! Enrolling Duke Cancer UAB Surgery CU Surgical Oncology Winship Cancer Institute of Emory University UChicago Surgery Markey Cancer Center Michigan Surgery Corewell Health Mayo Clinic Siteman Cancer Center Memorial Sloan Kettering Cancer Center Mount Sinai Health System Fox Chase Cancer Center UT Southwestern Medical Center + others opening soon!

A class photo that will make Yale Surgery grads smile.

Frederick Banting was awarded the US patent for insulin in 1923 & sold it for $1, saying: “Insulin does not belong to me, it belongs to the world” But by 2019, 1 out of every 4 patients who needed it was unable to afford insulin! Shameful! CVS Health Express Scripts Pharmacy Benefit Services OptumRx

This is going to be an awesome #CGSO program, congrats to you and the team at Mayo for getting it started!

Wow- what an amazing day of speakers @NCI_CCR_SB @NIHDirector Steven Libutti Dr. Patrick Hwu H Richard Alexander celebrating Dr Steven Rosenberg and past, present and Future of Cellular #Immunotherapy bit.ly/3TMfjhv

Dr. Rosenberg is a scientific pioneer. Our Chief Patient Officer and 14-year CCA survivor Melinda Bachini was in his groundbreaking clinical trial. We are grateful to him and his teams over the years for the hope they have given so many. Thank you, Dr. Rosenberg and National Cancer Institute!

Look at the conditions in which Ukrainian defenders find themselves while fighting for independence!

Pancreatic “ductal” adenocarcinoma is often not one of the most photogenic tumors, one of its many frustrating qualities (although far from its worst quality), but thanks Mayo Clinic Pathology PA for getting the perfect slice as makes good teaching case of what a bd-IPMN associated

🚨 Great alternatives to BioRender are now available!! 📢 NIAID News offers a collection of public figures and icons for everyone to use. Check it out at bioart.niaid.nih.gov

This is honestly kinda amazing from targeting just one tumor specific pMHC Requires a shift to targeting many pMHCs using many different (possibly personalized) TCRs but this feels like the a gradient ascent breadcrumb towards general purpose curative therapies.

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma. Co-authored by Alex Gustafson and Nicholas Klemen. Read full article. brnw.ch/21wTvmj

Researchers ask what happened to that lady who who participated in TIL trial at NIH nine years ago. Out there living her best life... 2016 research in NEJM nejm.org/doi/10.1056/NE… NY TImes write up nytimes.com/2016/12/07/hea… KRASKickers David S. Hong MD CrozrX Nicholas Klemen

Roundabouts are safer. They save lives. They cost less! They pollute less. Former Carmel, Indiana mayor @JimBrainard replaced nearly every stoplight in his town with them. It was a success:

What a life! Love it.

✅✅ A reminder by Dr. Rahaf Ajaj: She wasn’t on the Stanford list… but she made it to the Nobel stage. 🏅 Mary E. Brunkow, one of this year’s Nobel Prize winners in Medicine, has only 34 published papers and an H-index of 21. She never appeared in Stanford’s ranking of the

This is the most forward looking approach the FDA has taken with the expansion of scientific knowledge today. Well done Vinay Prasad MD MPH Dr. Marty Makary. I love these statements: "An appropriately designed study with a small sample size can support licensure of a product for which